The landscape of dementia prognosis has evolved dramatically with the appearance of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based checks that could detect Alzheimer's pathology many years right before signs or symptoms emerge. Though these technological improvements represent extraordinary progress in being familiar with neurodegenerative https://carlosd197blv7.iyublog.com/profile